CX Institutional’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$125K Sell
2,145
-89,071
-98% -$4.97M ﹤0.01% 833
2026
Q2
$4.96M Sell
91,216
-4,571
-5% -$223K 0.14% 154
2026
Q1
$4.11M Buy
+95,787
New +$4.12M 0.13% 178
2019
Q3
– Sell
-103
Closed -$2K – 840
2019
Q2
$2K Buy
+103
New +$2.16K ﹤0.01% 750

Other funds holding EXEL

CX Institutional's EXEL Position: Q3 2026 in Review

CX Institutional reduced its Exelixis (EXEL) stake by 98% in Q3 2026, selling an estimated $4.97M and leaving 2,145 shares worth $125K. The position accounts for ﹤0.01% of the portfolio, ranked #833.

CX Institutional first reported a position in EXEL in Q2 2019 and has held it in 4 quarters since. The position peaked at $4.96M in Q2 2026. 100 funds tracked by Wall St. Rank hold EXEL as of Q3 2026.

  • CX Institutional held 2,145 shares of Exelixis worth $125K as of Q3 2026.
  • CX Institutional sold 89,071 Exelixis shares in Q3 2026, an estimated $4.97M.
  • Exelixis made up ﹤0.01% of CX Institutional's portfolio in Q3 2026, its #833 holding.
  • CX Institutional first reported a position in Exelixis in Q2 2019 and has held it in 4 quarters since.
  • CX Institutional's Exelixis position peaked at $4.96M in Q2 2026.
  • 100 funds tracked by Wall St. Rank held Exelixis as of Q3 2026.

Based on CX Institutional's 13F filing for Q3 2026, filed 2 Oct 2026.